US Patent Issued to Tenaya Therapeutics on March 17 for "Plakophillin-2 gene therapy methods and compositions" (California Inventors)

ALEXANDRIA, Va., March 17 -- United States Patent no. 12,576,161, issued on March 17, was assigned to Tenaya Therapeutics Inc. (South San Francisco, Calif.).

"Plakophillin-2 gene therapy methods and compositions" was invented by Zhihong Jane Yang (Menlo Park, Calif.), Jaclyn Ho (San Mateo, Calif.), Chris Reid (San Bruno, Calif.) and Jin Yang (Belmont, Calif.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Provided herein are methods and compositions for plakophilin-2 gene therapy for treating heart diseases such as arrhythmogenic right ventricular cardiomyopathy (ARVC) or arrhythmogenic cardiomyopathy (ACM)."

The patent was filed on April 7, 2023, under Application No. 18/297,347.

*For further information, ...